Gene Query: MRPL18

Dataset Description Geneva Score
MeRIP-seq for heat shock in B-cell lymphoma cells 70.75
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 57.04
4sU-seq of HFF exposed to salt and heat stress 56.8
Transcriptome analysis in Neobractatin treated cells 37.02
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 33.6
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 33.6
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 32.99
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 31.38
The bromodomain protein BRD4 regulates splicing during heat shock 28.08
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 21.55
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 21.55
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 19.42
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 17.72
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 15.78
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.9
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 14.33
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 14.33
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 14.26
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 14.21
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 14.21
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 14.2
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 14.02
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 14.01
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 14.01
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 13.85
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 13.58
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 13.56
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 13.48
RNAseq of HEK293 cells after Chtop knockdown 13.39
Co-transcriptional loading of RNA export factors shapes the human transcriptome 13.39
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 13.22
hnRNP C is a key regulator of protein synthesis in mitosis 13.13
KLF6-dependent transcription in renal cancer cells 12.89
Seletive inhibition of CDK9 in DLBCL cell lines 12.85
Global analysis of enhancer targets: Mosaic-seq 12.81
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 12.35
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 12.35
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 12.27
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 12.27
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 12.04
Depicting early human development and germ cell origin with porcine embryos 11.88
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.86
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.8
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.72
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 11.6
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 11.54
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 11.37
FOXD3 is a novel tumor suppressor in lung cancer 11.34
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 11.29
The comparison of high-throughput single-cell RNA-seq methods 11.25
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 11.1
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 11.1
AMPK signaling for naïve pluripotency [Hs] 11.09
AMPK signaling for naïve pluripotency 11.09
Gene expression profiling of leukemia cells following asparagine depletion 10.97
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 10.86
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 10.62
RNA-seq in transgenic cells 10.61
Expression by CD133+ cells isolated from the adult human exocrine pancreas 10.26
Trans-differentiation of human adult peripheral blood T cells into neurons 10.13
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.11
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 10.06
Transcriptional profile in human S. haematobium infection 9.91
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.84
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 9.83
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 9.81
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 9.73
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 9.62
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 9.53
Spliceosomal disruption of the non-canonical BAF complex in cancer 9.41
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.4
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 9.37
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.36
The cohesin complex prevents Myc-induced replication stress 9.26
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.23
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 9.2
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.19
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 9.09
FBXW7 modulates stress response by post-translational modification of HSF1 9.09
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 9.08
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.96
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.95
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.87
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 8.86
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.84
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.76
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 8.74
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 8.74
LncRNA-GAS5 negative regulation of YAP-target genes expression 8.73
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.64
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 8.62
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 8.52
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 8.5
Gene expression profile of multiple myeloma cell lines treated with CB-5083 8.49
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 8.42
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 8.42
Transcriptional profiling of microglia; current state of the art and future perspectives 8.41
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.36
RNA-seq of naive and primed ES cells 8.25
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.23
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.22
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.2
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 8.18
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 8.18
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 8.16
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 8.15
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.14
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 8.04
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 7.99
Differential expression of genes in AD169-infected MRC5. 7.96
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.89
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.87
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.87
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 7.83
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.83
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.83
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.82
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.6
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.6
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.57
Mapping interactions for the TNIP2 hub protein 7.54
CROP-Seq in Primary Human T Cells 7.52
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.49
Differentially expressed genes post knock down of lincDUSP26 7.43
scRNASeq analysis of cycling cardiomyocytes 7.4
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.37
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.31
Effect of disulfiram treatment on pediatric high grade glioma 7.25
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.23
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 7.22
SLAM-seq for K562 endogenous mRNA decay 7.19
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.13
Transcriptional landscape changes during human embryonic stem cell derivation 7.07
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 6.98
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 6.98
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 6.98
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.93
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.93
Lysine benzoylation is a novel histone mark 6.87
Lysine benzoylation is a novel histone mark [RNA-seq] 6.87
RNA-Seq with and without RNase treatment in PCa cell lines 6.87
Regulation of protein translation during mitosis 6.86
Identification of renal resident macrophages across species 6.85
Genome-wide functional assessment of enhancer activities in the human genome 6.8
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 6.77
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.72
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 6.72
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.71
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.71
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.71
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.69
Transcriptome analysis of SKI knock-out in HL60 cells 6.67
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 6.67
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.63
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.62
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.62
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.56
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.48
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 6.46
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.45
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.42
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.39
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.36
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 6.3
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.29
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 6.28
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.26
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 6.25
The landscape of alternative splicing in aggressive prostate cancers 6.22
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.22
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.21
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.21
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.2
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.16
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.16
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 6.16
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.15
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.13
DART-seq: an antibody-free method for global m6A detection 6.09
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.08
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.08
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 6.06
RNA editing in nascent RNA affects pre-mRNA splicing 6.03
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.02
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.01
NRDE2 negatively regulates nuclear exosome functions 6.0
RNA-seq analyisis of PUM2 knockout cells 5.97
Region-specific Innate Antiviral Responses of the Human Epididymis 5.93
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.9
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 5.88
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.81
Global response to chemotherapy-induced apoptosis 5.81
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 5.81
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.8
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 5.75
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.75
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.69
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.69
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.69
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.67
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.6
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.53
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 5.53
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.45
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 5.45
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 5.45
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.42
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 5.38
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 5.36
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 5.35
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.33
MYC dependent mRNA translation shapes gene expression and cell biology 5.32
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.29
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 5.29
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.29
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 5.22
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 5.17
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 5.16
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.15
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.14
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.12
RNA sequencing of GlyH-101-treated MCF-7 cell line 5.12
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.1
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 5.1
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.08
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 5.05
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 5.05
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.05
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 5.04
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.02
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.01
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.01
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.0
Effect of FGF13 depletion on the H460 cell line 4.99
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.97
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 4.97
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 4.97
K562 polyA RNA-Seq 4.92
Genome-wide discovery of human splicing branchpoints [RNAse] 4.9
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.9
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.9
RNA-Seq analysis of breast cancer cells after shikonin treatment 4.86
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.85
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.8
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.8
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.79
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 4.78
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 4.77
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.73
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.71
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.71
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 4.71
RNA-Seq from human ILC transitional populations 4.71
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.68
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.63
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.63
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.6
Global transcriptome analysis of HAP1 cells 4.58
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.56
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.5
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.48
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.47
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.46
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.45
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.44
MicroRNA targetome analysis during HCMV infection 4.44
Systematic discovery of endogenous human ribonucleoprotein complexes 4.42
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.41
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 4.41
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.4
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.38
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.35
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.35
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 4.33
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.33
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 4.33
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 4.33
RNA sequencing of primary human platelets and in vitro cell lines 4.26
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.17
Cell responses to dysregulated VZV-induced cell-cell fusion 4.17
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.16
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.11
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.08
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 4.07
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.06
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.02
Stem and effector CD8 T-cells from human cancers 3.98
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 3.97
Characterization of human ILC2 subsets 3.96
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.92
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.89
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.86
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.86
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 3.85
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.81
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 3.79
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 3.79
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.77
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.76
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.75
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.75
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.75
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.74
HBEC-shp53-PCHD7 3.72
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.7
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.7
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.68
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.62
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.62
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 3.61
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.61
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.57
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.57
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.52
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 3.49
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.48
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.48
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 3.4
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.39
RNA-sequencing of healthy human skeletal myocytes 3.39
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.38
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.36
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.35
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.35
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.33
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.33
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 3.32
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.28
The pause-initiation limit restricts transcription activation in human cells 3.25
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.25
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.25
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 3.21
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.17
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.17
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.98
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.97
RNA-seq analysis upon ARID1B overexpression 2.94
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.89
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.84
Regulatory network controlling tumor-promoting inflammation in human cancers 2.82
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.82
Positively selected enhancer elements endow tumor cells with metastatic competence 2.78
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.77
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 2.75
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.74
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.74
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.68
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.65
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.64
MicroRNA-125a-5p overexpression in human macrophages 2.62
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.61
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.56
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.56
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.56
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.56
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.49
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 2.43
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.42
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.41
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.36
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.36
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.33
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.33
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.29
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.24
The DPYSL2 gene connects mTOR and schizophrenia 2.23
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.23
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.18
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.18
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.17
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.17
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.17
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.17
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.16
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.14
Molecular Criteria for Defining the Naive Human Pluripotent State 2.13
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.05
RNA seq with AML (NB4) cells upon FTO inhibition 2.04
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.03
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.03
Role of cervicovaginal microbiota in genital inflammation 2.01
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.01
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.01
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.0
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.0
Human Treg IL-12 stimulation 1.91
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.86
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.85
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.85
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.84
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.83
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.82
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.82
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.81
Effect of ILF3 on translation during homeostasis and the antiviral response 1.81
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.77
Genome-wide analysis of the Integrator complex (HTS) 1.77
Genome-wide analysis of the Integrator complex 1.77
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.73
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.73
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.7
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.67
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.67
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.66
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.64
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.63
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.63
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.57
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.55
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.43
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.43
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.41
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 1.4
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.4
Functional significance of the HIV-1 Tat signature amino acid residues 1.39
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.38
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.37
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.36
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.36
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.35
The MEF2B Regulatory Network - RNA-seq data 1.35
The MEF2B Regulatory Network 1.35
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.34
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.25
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.25
siRNA-mediated knockdown 1.21
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 1.18
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.18
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.13
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.13
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.13
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.11
RNA-seq data 1.08
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.06
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.04
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.04
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.99
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.96
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.96
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.95
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.94
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.91
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.91
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.88
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.86
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.85
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.8
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.78
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.74
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.66
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.64
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.64
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.63
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.61
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.6
Targeting MTHFD2 in Acute Myeloid Leukemia 0.57
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.53
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.53
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.52
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.5
p53 activity results in DNA replication fork processivity 0.5
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.46
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.46
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.45
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.45
Determining mRNA half-lives on a transcriptome-wide scale 0.44
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.44
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.44
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.43
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.37
Dermal endothelial cells of type 2 diabetic patients 0.36
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.33
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.32
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.31
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.3
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.3
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.29
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.28
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.28
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.28
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.27
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.23
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.22
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.22
EGR1-controlled transcriptome of T HESCs 0.22
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.17
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.17
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.13
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.13
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.13
Preclinical model of obesity and ER-positive breast cancer 0.13
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.12
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.11
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.09
Iron response of HepG2 cells 0.09
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.09
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.05
Global transcriptome analysis of WT versus HEB-/- hESCs 0.04
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation